Pilot randomized controlled trial of Chinese herbal treatment for HIV- associated symptoms

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 4, 1996, Pages 386-393

  Burack, Jeffrey H ^a,c   Cohen, Misha R ^b   Hahn, Judith A ^c   Abrams, Donald I ^a,c  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b Quan Yin Healing Arts Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acquired immunodeficiency syndrome; Alternative medicine; Chinese medicine; Human immunodeficiency virus; Quality of life

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ALTERNATIVE MEDICINE; ANTIVIRAL ACTIVITY; ARTICLE; CHINESE HERB; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TRADITIONAL MEDICINE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029787125     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199608010-00009     Document Type: Article

References (38)

1. Moss AR, Bacchetti P, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS-related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J 1988;296:745-50.
2. Volberding PA, Graham NM. Initiation of antiretroviral therapy in HIV infection: a review of interstudy consistencies. JAIDS 1994;7(suppl 2):S12-23.
3. Danner SA, Carr A, Leonard JM, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N Engl J Med 1995;333:1528-33.
4. Concorde Coordinating Committee. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994;343:871-81.
5. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med 1992;115:129-37.
6. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987;317: 185-91.
7. Lenderking WR, Gelber RD, Cotton DJ, et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. N Engl J Med 1994;330:738-43.
8. Abrams DT. Dealing with alternative therapies for HIV. In: Sande MA, Volberding P, eds. The medical management of AIDS, 4th ed. Philadelphia: W.B. Saunders, 1994.
9. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. N Engl J Med 1993;328:246-52.
10. Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer medicine: a study of patients, treatments and practitioners. Arch Intern Med 1984;101:105-12.
11. Cohen CJ, Eisenberg DM, Mayer KH, Delbanco TL. Prevalence of nonconventional medical treatments in HIV-infected patients: implications for primary care [Abstract]. Clin Res 1990;38:692A.
12. Kassler WJ, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med 1991;151:2281-8.
13. Cohen M. Chinese medicine in the treatment of chronic immunodeficiency: diagnosis and treatment. Am J Acupuncture 1990;18:111-22.
14. Sun Y. Chinese medicinal herbs as biological response modifiers. In: Lotzova E, Herberman RB, eds. Natural immunity, cancer and biological response modification. Basel: Karger, 1986.
15. Sun Y. The role of traditional Chinese medicine in supportive care of cancer patients. Recent Results Cancer Res 1988; 108:327-34.
16. Klayman DL. Qinghaosu (Artemisinin), an antimalarial drug from China. Science 1985;228:1049-55.
17. Sun Y, Hersh EM, Lee S-L, McLaughlin M, Loo TL, Mavligit GM. Preliminary observations on the effects of the Chinese medicinal herbs Astragalus membranaceus and Ligustrum lucidum on lymphocyte blastogenic responses. J Biol Response Mod 1983;2:227-37.
18. Chu D-T, Wong W, Mavligit GM. Immunotherapy with Chinese medicinal herbs. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo. J Clin Lab Immunol 1988;25:125-9.
19. Sun Y, Hersh EM, Talpaz M, et al. Immune restoration and/or augmentation of local graft versus host reaction by traditional Chinese medicinal herbs. Cancer 1983;52:70-3.
20. Chang RS, Yeung HW. Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs. Antiviral Res 1988;9:163-76.
21. Rabinowitz N. Acupuncture and the AIDS epidemic: reflections on the treatment of 200 patients in four years. Am J Acupuncture 1987;15:35-42.
22. Smith MO. AIDS: results of Chinese medical treatment show frequent symptom relief and some apparent long-term remissions. Am J Acupuncture 1988;16:105-12.
23. Ridker PM, McDermott V. Comfrey herb tea and hepatic veno-occlusive disease. Lancet 1989;2:657-658.
24. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992; 117:129-32.
25. Chan TYK, Chan JCN, Tomlinson B, Critchley JAJH. Chinese herbal medicines revisited: a Hong Kong perspective. Lancet 1993;342:1532-4.
26. Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994;121:729-35.
27. Centers for Disease Control and Prevention. Revision of the case definition for acquired immunodeficiency syndrome. MMWR 1987;36(suppl 2S):1-15.
28. Cleary PD, Fowler FJ Jr, Weissman J, et al. Health-related quality of life of persons with AIDS. Med Care 1993;31:569-80.
29. Ware JE. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993.
30. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection. Med Care 1991;29:786-98.
31. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1977;1:385-401.
32. Spielberger CD, Gorsuch RL, Lushene R. Self-evaluation questionnaire. Palo Alto, CA: Consulting Psychologists Press, 1968.
33. Jaescheke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
34. Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
35. DeGruttola V, Lange N, Dafni U. Modeling the progression of HIV infection. J Am Stat Assoc 1991;86:569-77.
36. Sullivan MD. Placebo controls and epistemic control in orthodox medicine. J Med Philos 1993;18:213-31.
37. Institute of Medicine. Assessing medical technologies. Washington, D.C.: National Academy Press, 1985.
38. Delbanco TL. Bitter herbs: mainstream, magic, and menace. Ann Internal Med 1994;121:803-4.